TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biopart AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
210
|
175
|
383 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-130
|
-212
|
40 |
| EBITDA |
-131
|
-213
|
40 |
| Total assets |
519
|
737
|
1,141 |
| Current assets |
519
|
737
|
1,141 |
| Current liabilities |
200
|
273
|
61 |
| Equity capital |
319
|
464
|
1,038 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
61.5%
|
63.0%
|
91.0% |
| Turnover per employee |
210
|
175
|
383 |
| Profit as a percentage of turnover |
-61.9%
|
-121.1%
|
10.4% |
| Return on assets (ROA) |
-25.0%
|
-28.8%
|
3.5% |
| Current ratio |
259.5%
|
270.0%
|
1870.5% |
| Return on equity (ROE) |
-40.8%
|
-45.7%
|
3.9% |
| Change turnover |
41
|
-210
|
-1,981 |
| Change turnover % |
24%
|
-55%
|
-84% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-50% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.